How Beta-Glucans Epigenetically Reprogram Immune Cells

Mushrooms & Immune Health

Science 2014

A 2014 paper in Science mapped the full epigenomes of human monocytes before and after beta-glucan training, identifying specific histone marks that explain how immune cells remember previous encounters with fungal compounds at the molecular level.

Saeed et al., Science, 2014

H3K4me3

the histone mark deposited at cytokine gene switches in trained immune cells, the molecular signature of immune memory

Warburg shift

trained immune cells switch to aerobic glycolysis before epigenetic reprogramming occurs. Metabolism drives gene changes

Persists

epigenetic changes in macrophages remain even after the beta-glucan training stimulus is removed

Saeed et al., Science, 2014

View as image ↗

When researchers describe mushrooms as "boosting immunity," they are usually describing something much more specific. The mechanism is not a general dial that gets turned up. A class of carbohydrates in mushroom cell walls, called beta-glucans, binds to a receptor on the surface of innate immune cells and triggers a chain of molecular events that ends with the cell's genome being chemically rewritten. The immune cell becomes faster at responding to threats. Not because of a temporary chemical stimulus, but because the genes it uses to mount an immune response are now marked for easier access.

This process has a name: trained immunity. The article below covers the specific molecular mechanism: how beta-glucans reprogram immune cells at the level of their chromosomes, step by step. For the broader picture of what trained immunity means for mushroom supplementation, see Mushrooms and Trained Immunity: The New Frontier and the full guide to mushroom beta-glucans and immunity.

The Receptor That Starts Everything: Dectin-1 and Beta-Glucan Recognition

Before any epigenetic reprogramming can happen, beta-glucan molecules need to be recognized by the immune cell. This recognition happens at the cell surface.

Monocytes and macrophages (the frontline innate immune cells that patrol the body for threats) carry a receptor called Dectin-1 on their outer membrane. Dectin-1 is a pattern recognition receptor, a category of sensor that the immune system uses to detect structural signatures common to groups of pathogens. Beta-glucans, the branched polysaccharide chains that form part of fungal cell walls, have a distinctive structure that Dectin-1 evolved to detect.

A 2009 review by Brown and Gordon established the receptor biology in detail: Dectin-1 and its related partner Dectin-2 recognize the beta-1,3 and beta-1,6 linkages that give mushroom beta-glucans their branched structure.^[1] When Dectin-1 encounters a beta-glucan molecule, it clusters with neighboring Dectin-1 receptors at the contact point, forming a tight junction between the cell membrane and the beta-glucan source called a phagocytic synapse. This clustering is what activates the receptor and begins signaling inside the cell.

For a focused look at Dectin-1 biology and how different mushrooms interact with it, see The Dectin-1 Receptor: How Your Body Recognizes Mushroom Beta-Glucans.

Step by Step: The Signaling Cascade That Rewires the Cell

Once Dectin-1 is activated, it sends signals into the cell through a chain of protein activations. Each protein in the chain switches on the next. The endpoint of this chain is an enzyme complex called mTOR (the mechanistic target of rapamycin), which coordinates the cell's metabolism.

A 2022 review by Mata-Martínez and colleagues, published in Frontiers in Immunology, updated the detailed map of how this cascade works:^[2]

1. Dectin-1 binds beta-glucan and clusters into the phagocytic synapse.
2. Syk kinase activates. Syk is an enzyme (a protein that drives chemical reactions) that attaches to the cytoplasmic tail of Dectin-1 when the receptor is occupied. Syk becomes active and starts phosphorylating (chemically modifying) other proteins in the chain.
3. Raf-1 and PKC-δ pathways activate in parallel, adding a second signaling route that amplifies the signal.
4. NF-κB activates. NF-κB is a transcription factor, a protein that travels to the nucleus and turns on gene expression. It activates genes involved in inflammation, cytokine production, and cell survival.
5. mTOR activates. Downstream of Syk and in coordination with NF-κB signaling, mTOR switches on. This is the step where the cell's metabolism changes, setting the stage for epigenetic reprogramming.

The Mata-Martínez 2022 review also identified non-canonical pathways: Dectin-1 can signal through mechanisms not involving Syk, including interactions with Toll-like receptors on the cell surface that further amplify the trained immunity response.^[2]

Why the Cell Switches Its Energy Source First

Something unusual happens to immune cells during trained immunity induction before any epigenetic changes occur: the cell changes how it makes energy.

Normal cells produce most of their energy through a process called oxidative phosphorylation, which takes place inside mitochondria and is highly efficient. Cells undergoing trained immunity switch to a less efficient method called aerobic glycolysis: they break down glucose rapidly in the cell's fluid (the cytoplasm) even though oxygen is available for the more efficient route. This is called the Warburg effect, named after the researcher who first described it in cancer cells. It turns out that highly active immune cells use the same strategy.

The Netea 2016 framework paper, published in Science, identified this metabolic rewiring as a key intermediate step: mTOR activates Akt, which activates Hif1α (a transcription factor originally described in cells adapting to low oxygen). Hif1α drives the cell toward aerobic glycolysis.^[3]

Why does this matter for epigenetics? The aerobic glycolysis pathway generates elevated levels of specific metabolites (chemical byproducts of metabolism) including succinate, fumarate, and acetyl-CoA. These metabolites are the raw materials for the chemical reactions that put epigenetic marks on chromosomes. Without the Warburg shift providing them in elevated concentrations, the epigenetic enzymes don't have enough substrate to place their marks efficiently.

Metabolism drives gene regulation. The Warburg effect is not a side effect of trained immunity; it is a required step in the mechanism.

The Epigenetic Bookmarks: What H3K4me3 and H3K27ac Actually Mean

Inside every cell, DNA is wrapped tightly around proteins called histones, like thread wound around a spool. Genes near a histone spool can be difficult for the cell's gene-reading machinery to access if the spools are wound too tightly. One way cells regulate which genes are active is by chemically modifying the histone proteins themselves. These modifications change how tightly DNA wraps and how accessible the nearby genes are.

Two specific modifications are the signatures of trained immunity:

H3K4me3 is shorthand for a chemical modification on histone H3 (one of the core histone proteins) at a specific location on the protein called lysine 4. The "me3" means three methyl groups (small chemical groups) have been added at that location. This mark is associated with actively transcribed genes, meaning genes that the cell is currently reading and using. When H3K4me3 appears at the switch for a gene, it means that gene is primed for activation.

H3K27ac is an acetylation mark (an acetyl group added to histone H3 at lysine 27) that marks active enhancers, the regulatory sequences that boost gene expression from a distance.

The landmark 2014 Science paper by Saeed and colleagues mapped the full epigenomes of human monocytes that had been trained with beta-glucan and compared them to untrained monocytes.^[4] The result: trained monocytes showed H3K4me3 and H3K27ac marks deposited specifically at the gene switches (promoters) for a set of cytokines (IL-6, TNF-α, and IL-1β) that macrophages use to mount inflammatory responses.

In plain language: the cells left bookmarks in the genome. Every time a trained macrophage needs to produce TNF-α to fight an infection, the gene is already marked with H3K4me3. The cell's gene-reading machinery finds it faster and activates it more efficiently than an untrained cell could. That is what "epigenetic reprogramming" means in trained immunity: not that the DNA sequence changed, but that the physical accessibility of immune genes changed, persistently, in a way that makes the cell faster and stronger at its job.

The Saeed 2014 paper also confirmed this happens in human (not just mouse) monocytes, and that the reprogramming occurs during the process of monocyte-to-macrophage differentiation, when the monocyte in circulation encounters beta-glucan and begins transforming into the tissue-resident macrophage form.^[4]

The first experimental proof of the H3K4me3 mechanism came two years earlier, from Quintin and colleagues in 2012, using beta-glucan from Candida cell walls in mice.^[5] That study showed that mice lacking T and B cells (and therefore having no adaptive immune memory at all) could still gain protection against reinfection through trained monocytes carrying H3K4me3 marks. This was the first experimental demonstration that innate immune cells can carry epigenetic memory that functions like the adaptive immune system's memory, but through an entirely different molecular mechanism.

Why the Changes Persist After the Beta-Glucan Is Gone

A question that matters practically: the training stimulus (beta-glucan) doesn't stay in the body permanently. Once it is metabolized and cleared, why does the trained immunity persist?

A 2021 study by Ma and colleagues, published in Frontiers in Immunology, addressed this by examining what happens to trained macrophages after the stimulus is removed.^[6] Even in already-differentiated macrophages (cells that had already completed the monocyte-to-macrophage transition before beta-glucan exposure), beta-glucan training induced distinct epigenetic changes that persisted after the training stimulus was washed out. The cells maintained their enhanced cytokine response to secondary stimulation.

The reason persistence is possible is in the nature of epigenetic marks themselves. Histone methylation and acetylation are chemically stable modifications. They are maintained through cell division by enzymes that copy the mark onto the new histones after replication. Unless actively removed by demethylase or deacetylase enzymes, these marks remain on the chromatin. The trained macrophage's enhanced response is written into its chromatin structure, not into the presence or absence of a circulating chemical.

This persistence explains why trained immunity from beta-glucan exposure can last weeks to months after the exposure period ends, at least in laboratory models.

Does This Apply to Mushroom Beta-Glucans Specifically?

The mechanistic work described above used beta-glucan from Candida albicans (a yeast that causes infections) for the initial proof-of-concept experiments. The question is whether mushroom-derived beta-glucans, which have structural differences from yeast beta-glucans, trigger the same mechanism.

Evidence points toward a class effect across fungal beta-glucans. A 2024 study by Vuscan and colleagues, published in Frontiers in Immunology, found that beta-glucans from Saccharomyces cerevisiae (baker's yeast) are potent trained immunity inducers via the same Dectin-1 pathway.^[7] Structurally, Saccharomyces beta-glucans are more similar to Agaricus and other edible mushroom beta-glucans than Candida beta-glucans are. The Vuscan 2024 findings strengthen the case that the mechanism operates across fungal beta-glucans as a class, not only the specific Candida-derived beta-glucan used in earlier proof-of-concept work.

A 2021 review by De Marco Castro and colleagues specifically addressed beta-1,3/1,6-glucan structural variants from mushrooms and their differential effects on immune cells, confirming that mushroom beta-glucans bind Dectin-1 and induce trained immunity responses, while noting that structural differences (branch length, degree of polymerization) affect potency.^[3]

The De Marco Castro review identified gaps that remain in clinical translation: most mechanistic studies used purified or semi-purified beta-glucan preparations rather than whole mushroom products. Whether the beta-glucans in cooked or powdered mushrooms, after digestion, are still recognized efficiently by gut-resident macrophages' Dectin-1 receptors is not yet fully characterized.

What the Reprogrammed Cell Can Actually Do Differently

The epigenetic changes produce a functional outcome that the Ma 2021 and Quintin 2012 studies measured directly: trained macrophages produce substantially more TNF-α, IL-6, and IL-1β when they encounter a new threat compared to untrained macrophages of the same type.

TNF-α (tumor necrosis factor alpha) is a cytokine that coordinates inflammation, directly kills some infected cells, and recruits additional immune cells to infection sites. IL-6 amplifies the inflammatory response and drives fever (which slows pathogen replication). IL-1β activates local immune cells and increases vascular permeability at infection sites, helping immune cells migrate into tissue.

A trained macrophage producing more of all three, faster, means a more aggressive early response to infection before the adaptive immune system (T cells and antibodies) has time to mount its specific response. The innate immune system is the first line: it buys time. Trained innate cells that respond faster and more vigorously make the first-line defense meaningfully more effective.

The Moorlag 2020 study demonstrated this functional consequence in an important way: beta-glucan-trained human monocytes showed enhanced anti-mycobacterial activity, and beta-glucan-pretreated mice had significantly lower tuberculosis bacterial burden when infected with Mycobacterium tuberculosis. Trained immunity induced by fungal beta-glucans produced protection against a completely different pathogen (bacteria, not fungi), confirming that the enhanced response is broad-spectrum rather than specific to the original training stimulus.

For downstream practical implications, see How Medicinal Mushrooms Activate Macrophages and Mushroom Supplements Before Vaccination: Immune Priming Evidence.

What This Research Can and Cannot Tell Us

The mechanistic picture from Dectin-1 to H3K4me3 is unusually well-developed for a dietary supplement area. The Science-level publications from the Netea group establish the core mechanism robustly. The Saeed 2014 epigenome paper specifically used human cells. The persistence data from Ma 2021 shows the changes are durable.

What the mechanistic research cannot tell us directly: whether eating mushrooms as food, or taking mushroom supplements in doses typical of retail products, delivers enough beta-glucan to the right immune cell populations to produce meaningful trained immunity in a living human. The gap between a well-characterized mechanism in cultured cells and a measurable immune benefit in a person eating shiitake mushrooms several times a week is substantial.

The beta-glucan concentrations used in mechanistic experiments are often higher than those achievable from food or supplement doses. Oral bioavailability of beta-glucans, digestion by gut enzymes, and the proportion that reaches circulating monocytes or gut-resident macrophages are all partially characterized at best. The Case 2024 study, showing that oral Agaricus bisporus products reach bone marrow and induce trained immunity in mice, is the most promising bridge between mechanism and dietary use. Human trials measuring trained immunity endpoints after dietary mushroom consumption are a meaningful gap in the current evidence base.

The mechanism is real, well-characterized, and plausible as an explanation for why mushroom-eating populations and mushroom supplement trials consistently show enhanced immune responses. The dose-response relationship in dietary humans is the open question.

The Bottom Line

Mushroom beta-glucans trigger trained immunity through a specific molecular cascade: Dectin-1 receptor binding drives Syk/Raf-1/NF-κB signaling that activates mTOR, mTOR induces a Warburg metabolic shift via Akt/Hif1α, and the resulting metabolic byproducts fuel epigenetic enzymes that deposit H3K4me3 and H3K27ac marks at cytokine gene promoters. These marks make immune response genes physically more accessible, producing faster and stronger cytokine output when the trained cell encounters a new threat. A landmark 2014 Science paper confirmed this mechanism in human monocytes. The epigenetic marks persist after the training stimulus is removed. The primary gap between the mechanism research and dietary applications is establishing which doses of which mushroom products, via which routes of administration, produce meaningful trained immunity in living humans.

Frequently Asked Questions

How do beta-glucans change gene expression in immune cells?

Beta-glucans bind the Dectin-1 receptor on monocytes and macrophages, triggering a signaling chain that activates mTOR and drives a metabolic shift to aerobic glycolysis. The metabolic byproducts of this shift provide the chemical building blocks for epigenetic enzymes, which deposit H3K4me3 and H3K27ac marks at the gene switches for cytokines including IL-6, TNF-α, and IL-1β. These marks make the cytokine genes physically more accessible to the cell's gene-reading machinery, so the trained cell produces more cytokines faster when it encounters a new immune stimulus.

What epigenetic changes do beta-glucans cause in monocytes?

Beta-glucan-trained human monocytes accumulate two specific histone modifications: H3K4me3 (trimethylation of histone H3 at lysine 4) and H3K27ac (acetylation of histone H3 at lysine 27) at the promoter regions of key immune response genes. These marks were characterized in a landmark 2014 Science paper by Saeed and colleagues, who compared the full epigenomes of trained and untrained human monocytes. The marks function as molecular bookmarks that keep frequently-needed immune genes primed for rapid activation.

What is H3K4me3 and what does it do in trained immunity?

H3K4me3 is a histone modification: three methyl groups added to the protein histone H3 at a specific position (lysine 4). Histones are the proteins that DNA wraps around. The H3K4me3 mark appears at gene promoters (the regulatory sequences that switch genes on) and makes those genes more accessible to the cell's gene-reading machinery. In trained immunity, beta-glucan exposure causes H3K4me3 to accumulate at the promoters of cytokine genes in monocytes and macrophages, so those cells can activate their immune response genes faster and more strongly when they encounter a new threat.

How does the mTOR pathway connect to immune memory?

mTOR (the mechanistic target of rapamycin) is a protein complex that coordinates cellular metabolism and growth. In the trained immunity cascade, Dectin-1 binding by beta-glucan activates mTOR through a signaling chain involving Syk, Raf-1, and NF-κB. Activated mTOR then drives the cell toward aerobic glycolysis (the Warburg effect) via Akt and Hif1α. This metabolic shift generates elevated levels of acetyl-CoA and other metabolites that epigenetic enzymes need to deposit H3K4me3 marks on histones. Blocking mTOR with rapamycin prevents trained immunity from forming, confirming mTOR is a required step rather than a coincidental activation.

What is the Warburg effect in immune cells?

The Warburg effect is a metabolic switch in which cells produce energy primarily through aerobic glycolysis (breaking down glucose in the cytoplasm) rather than the more efficient mitochondrial oxidative phosphorylation pathway, even when oxygen is available. Originally described in cancer cells, the Warburg effect also occurs in highly active immune cells. In trained immunity, beta-glucan exposure activates mTOR, which drives immune cells into aerobic glycolysis via Akt and Hif1α. The metabolic byproducts of this glycolytic activity, including elevated acetyl-CoA, provide the chemical substrate for the histone modification enzymes that deposit epigenetic training marks.

Sources & References

1. 1. Source details for this reference are not yet available.
2. 2RTHM-01584·Mata-Martínez, Pablo et al. (2022). “Dectin-1 Signaling Update: New Perspectives for Trained Immunity..” Frontiers in immunology.Study breakdown →PubMed →↩
3. 3RTHM-00810·Netea, Mihai G et al. (2016). “Trained immunity: A program of innate immune memory in health and disease..” Science (New York.Study breakdown →PubMed →↩
4. 4RTHM-00640·Saeed, Sadia et al. (2014). “Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity..” Science (New York.Study breakdown →PubMed →↩
5. 5RTHM-00485·Quintin, Jessica et al. (2012). “Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes..” Cell host & microbe.Study breakdown →PubMed →↩
6. 6. Source details for this reference are not yet available.
7. 7RTHM-02009·Vuscan, Patricia et al. (2024). “Potent induction of trained immunity by Saccharomyces cerevisiae β-glucans..” Frontiers in immunology.Study breakdown →PubMed →↩